New blood vessel graft for emergency arm or leg injuries
Part of Heart & circulation, Injuries & trauma clinical trials.
This study tests a new blood vessel replacement (called Symvess) in people who have severe injuries to arteries in their arms or legs. The goal is to see if it works safely in real-life emergency settings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have an injury to a major artery in your arm or leg that needs urgent surgery to restore blood flow.
- You must be able to provide informed consent yourself or have a legal representative who can.
- You should have a life expectancy of at least one year.
- You must have a stable place to live and a support system to help with follow-up for a year.
- You must have health insurance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new artificial blood vessel, called SYMVESS, to repair severe arm or leg artery injuries in teenagers. The goal is to restore blood flow and prevent limb loss when using the patient's own vein is not an option.
This trial tests a new type of artificial blood vessel (graft) for people who need a bypass or replacement of an artery in the belly, leg, or groin. The goal is to see if it works well to restore blood flow when a person's own vein is not available.
This trial studies whether a newer “tissue-engineered” blood vessel graft is safe and works well in children who need a specific heart surgery connection outside the heart. It may help by offering a new type of graft, but your team will screen for size and medical factors first.
This trial studies a new stent-like vascular scaffold to improve blood flow in people with symptomatic blockage in the thigh/knee artery. It may help reduce symptoms from narrowed or blocked arteries, but you must meet several artery and health requirements.
This trial tests a lab-made blood vessel (called an ATEV) used as a bypass graft during heart surgery. The ATEV is designed for people who don't have enough healthy leg vein for standard bypass grafts, and it may help restore blood flow to the heart more safely.
This study tests a new way to restore blood flow in the lower leg for people with chronic limb-threatening ischemia, a serious condition where leg wounds won't heal due to poor circulation. If it works, this treatment could help save the leg and avoid amputation.
Hear when a new Vascular Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.